|
|
|
|
|
|
|
Journal issues
|
Cancer Gene Therapy
ScopeCancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy as applied to cancer research. Types of manuscripts considered include: Original Research Articles. Articles should include, as appropriate, a clear statement of purpose; a historical review when desirable; a description of the procedures, methods, and subjects or materials used (previously published procedures require only references to the original); a full report of the findings, including discussion and references to relevant findings of other researchers. Case Reports. Include an introduction justifying the reporting of the case; a description of the case; and discussion. Preliminary Communications. Brief descriptions of important innovative developments will be considered for preliminary publication. Review Articles. Updates on progress in the main field of Drug Resistance/Sensitivity Gene Therapy, Tumor Suppressor and Anti-Oncogene Therapy, Cytokine/Tumor Immunotherapy, etc. Industry Perspective. Descriptions of the newest technology being developed in the corporate sector. Letters to the Editor. Brief comments on articles published in the Journal or other information of interest to our readers.
Last Updated 3 January 2001 |
